Page last updated: 2024-08-23

sufentanil and Hepatitis

sufentanil has been researched along with Hepatitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chai, X; Guo, F; Han, H; Shu, S; Wang, S; Yang, X; Yin, Y; Zhou, L; Zhou, W1

Other Studies

1 other study(ies) available for sufentanil and Hepatitis

ArticleYear
Sufentanil Protects the Liver from Ischemia/Reperfusion-Induced Inflammation and Apoptosis by Inhibiting ATF4-Induced TP53BP2 Expression.
    Inflammation, 2021, Volume: 44, Issue:3

    Topics: Activating Transcription Factor 4; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Hypoxia; Cell Line; Disease Models, Animal; Gene Expression Regulation; Hepatitis; Hepatocytes; Inflammation Mediators; Liver; Male; Rats, Inbred BUF; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Sufentanil

2021